Pharmacodynamic Study on Removing Blood Stasis and Stopping Bleeding for Extracts of and

WU Yu-qiang; JIANG Lin; ZHONG Zheng-xian; LIU Yuan-huan

您当前的位置：

首页 >

文章列表页 >

Pharmacodynamic Study on Removing Blood Stasis and Stopping Bleeding for Extracts of and

更新时间：2024-01-04

- Pharmacodynamic Study on Removing Blood Stasis and Stopping Bleeding for Extracts of and
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 17, Issue 12, Pages: 132-136(2011)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2011
- 稿件说明：
移动端阅览
WU Yu-qiang, JIANG Lin, ZHONG Zheng-xian, et al. Pharmacodynamic Study on Removing Blood Stasis and Stopping Bleeding for Extracts of and [J]. Chinese journal of experimental traditional medical formulae, 2011, 17(12): 132-136.
DOI：

WU Yu-qiang, JIANG Lin, ZHONG Zheng-xian, et al. Pharmacodynamic Study on Removing Blood Stasis and Stopping Bleeding for Extracts of and [J]. Chinese journal of experimental traditional medical formulae, 2011, 17(12): 132-136. DOI：

摘要

目的: 研究常春卫矛提取物(EH)和爬行卫矛提取物(EF)的止血消瘀作用。方法: 将小鼠随机分成8组

分别设EH和EF的高、中、低剂量(32.0

16.0

8.0 g ·kg-1)组

阿斯匹林(100 mg ·kg-1)组和空白组

采用毛细玻璃管法测量小鼠凝血时间;将小鼠随机分为9组

分别设EH和EF的高、中、低剂量组

空白组

模型组

复方扶芳藤合剂(百年乐)(5.2 g ·kg-1)组

建立血虚小鼠模型

观察小鼠WBC

RBC

Hb的变化;将大鼠随机分成9组

分别设EH和EF的高、中、低剂量组

空白组

模型组

复方丹参片(0.6 g ·kg-1)组

建立急性血瘀证大鼠模型

观察EH和EF对大鼠血液流变学指标的影响。结果: EH高、中剂量组和EF高剂量组能显著延长凝血时间;百年乐及EF高、中剂量组对WBC

RBC数及Hb有明显增加趋势;EH高、中剂量组能明显降低急性"血瘀"证大鼠全血黏度和血浆黏度

红细胞刚性指数

高剂量组还能降低红细胞压积、血沉和TC、TG含量

EF高、中剂量组降低全血黏度和血浆黏度、血沉、全血还原黏度

高剂量还能降低红细胞刚性指数、红细胞聚集指数、红细胞压积及TG含量。结论: EH和EF均具有抗凝血和活血化瘀作用。

Abstract

Objective: To investigate the effects of Euonymus fortunei. extract (EF) and E. hederaceus extract (EH) on removing blood stasis and stopping bleeding. Method: Kunming mice were randomly divided into eight groups:EH and EF treatment (32.0

16.0

8.0 g ·kg-1

ig) groups

aspirin(100 mg ·kg-1

ig) group and control group

the anticoagulant effect of EH and EF was observed by measuring blood coagulation time in mice with capillary tube method.In another study

Kunming mice randomly divided into nine groups:EH and EF treatment (32.0

16.0

8.0 g ·kg-1

ig) groups

Fufang Fufangteng mixture(bainianle)(5.2 g ·kg-1

ig)group

model group and control group

to observe the changes of WBC

RBC

Hb level. Wistar rats were randomly divided into nine groups:EH and EF treatment (32.0

16.0

8.0 g ·kg-1

ig) groups

Fufang Dansen tablet(0.6 g ·kg-1

ig)group

model group and control group. Rat model of acute blood stasis syndrome was established to observe the influence of EF and EH on hemorheological parameters. Result: Under the doses of EH (32.0

16.0 g ·kg-1) and EF(32.0 g ·kg-1)

the experiments showed that EH and EF could significantly extend the clotting time;Under the doses of EF(32.0

16.0 g ·kg-1)

EF and bainianle could increase the WBC

RBC count and HB value significantly in hemopenia mice;Under the doses of EH (32.0

16.0 g ·kg-1)

EH could reduce the parameters of hemorheology in rats with acute blood stasis syndrome

including whole blood viscosity

plasma viscosity

rigidity index of RBC

and EH (32.0 g ·kg-1) could reduce HCT

erythrocyte sedimentation rate (ESR)

the content of TC and TG. Under the doses of EF(32.0

16.0 g ·kg-1)

EF could reduce the parameters of hemorheology in rats with acute blood stasis syndrome

including whole blood viscosity

plasma viscosity

ESR

whole blood reduced viscosity

and EF (32.0 g ·kg-1) could reduce rigidity index of RBC

aggregation index of RBC

HCT

ESR and the content of TG. Conclusion: Both extracts have the effects of activationg blood circulation and removing blood stasis.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰